Arcan Guven

Dr. Arcan Guven

orcid

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
NPNicole E. Pellegrino
Nicole E. Pellegrino
AGArcan Guven
Arcan Guven
KGKayleigh Gray
Kayleigh Gray
PSPunit Shah
Punit Shah
GKGargi Kasture
Gargi Kasture
MKMichael Kiebish
Michael Kiebish
Post-translational modifications of proteins ensure optimized cellular processes, including proteostasis, regulated signaling, cell survival, and stress adaptation to maintain a balanced homeostatic state. Abnormal post-translational modifications are associated with cellular dysfunction and the occurrence of life-threatening diseases, such as cancer and neurodegenerative diseases. Therefore, some of the frequently seen protein modifications have been used as disease markers, while others are targeted for developing specific therapies. The ubiquitin and ubiquitin-like post-translational modifiers, namely, small ubiquitin-like modifier (SUMO) and neuronal precursor cell-expressed developmentally down-regulated protein 8 (NEDD8), share several features, such as protein structures, enzymatic cascades mediating the conjugation process, and targeted amino acid residues. Alterations in the regulatory mechanisms lead to aberrations in biological processes during tumorigenesis, including the regulation of tumor metabolism, immunological modulation of the tumor microenvironment, and cancer stem cell stemness, besides many more. Novel insights into ubiquitin and ubiquitin-like pathways involved in cancer biology reveal a potential interplay between ubiquitination, SUMOylation, and NEDDylation. This review outlines the current understandings of the regulatory mechanisms and assay capabilities of ubiquitination, SUMOylation, and NEDDylation. It will further highlight the role of ubiquitination, SUMOylation, and NEDDylation in tumorigenesis.

3 May 2019 in Journal of Pharmaceutical and Biomedical Analysis
Verified
Journal Article
Closed access
AGArcan Guven
Arcan Guven
WWWenfang S. Wu
Wenfang S. Wu
SPSaurabh Patil
Saurabh Patil
KGKarthiga Gokul
Karthiga Gokul
PTPoornima Tekumalla
Poornima Tekumalla
MKMichael A. Kiebish
Michael A. Kiebish

23 February 2022 in Analytical Biochemistry
Verified
Journal Article
Closed access
KPKuan-Wei Peng
Kuan-Wei Peng
AKAllison Klotz
Allison Klotz
AGArcan Guven
Arcan Guven
KGKayleigh Gray
Kayleigh Gray
TFTracey Friss
Tracey Friss
MKMichael Kiebish
Michael Kiebish

1 April 2021 in Journal of Pharmaceutical and Biomedical Analysis
Verified
Journal Article
Closed access
AGArcan Guven
Arcan Guven
KGKayleigh Gray
Kayleigh Gray
KPKuan-Wei Peng
Kuan-Wei Peng
AKAllison Klotz
Allison Klotz
MKMark D. Kellogg
Mark D. Kellogg
MKMichael A. Kiebish
Michael A. Kiebish